---
aliases: >-
  /news/biofourmis-earns-fda-breakthrough-device-designation-for-digital-therapeutic-for-heart-failure
archetype: curated-content
author:
  - Radhika Narayanan
basePath: /news/
breadcrumbLinks:
  - /
  - /news/
  - ''
breadcrumbs:
  - Home
  - News
  - >-
    Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic
    for Heart Failure
categories:
  - 'Medical Subject Headings (MeSH): Cardiology'
  - 'U.S. Food and Drug Administration (FDA): Medical Device Data Systems'
  - 'Medigy: Digital Medical Devices'
categorySlug:
  - 'medical subject headings (mesh): cardiology'
  - 'u.s. food and drug administration (fda): medical device data systems'
  - 'medigy: digital medical devices'
categoryUrl:
  - topic/medical-subject-headings-mesh-cardiology
  - topic/u-s-food-and-drug-administration-fda-medical-device-data-systems
  - topic/medigy-digital-medical-devices
categoryLabel:
  - Cardiology
  - Medical Device Data Systems
  - Digital Medical Devices
contentCategories: netspective-medigy-news-curated-content
institution: null
offering: null
layOut: single
date: '2021-08-02'
description: >-
  – Biofourmis, a Boston-based global leader in virtual care and digital
  therapeutics, announced its BiovitalsHF® solution is the first-ever heart
  failure digital therapeutic to receive a Breakthrough D
favIconImage: null
featuredImage:
  alt: >-
    Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic
    for Heart Failure
  format: JPEG
  href: dcc07e0b-7e22-59e2-94da-23a5b92ee9e4-featuredImage.jpeg
  size:
    - 594
    - 1194
  valid: true
  workPackage: 7399
  wpAttachment:
    fileName: Curated_Featured_Image.png
    link: /api/v3/attachments/16214/content
featuredPdf: null
htmlMetaData:
  author: null
  description: >-
    Biofourmis receives FDA Breakthrough Device designation for the first-ever
    heart failure digital therapeutic, BiovitalsHF® solution.
  generator: null
  viewport: 'width=device-width, initial-scale=1'
  articlemodified_time: '2021-07-30T18:18:39+00:00'
  articlepublished_time: '2021-07-30T18:18:36+00:00'
  msvalidate.01: null
  ogdescription: >-
    Biofourmis receives FDA Breakthrough Device designation for the first-ever
    heart failure digital therapeutic, BiovitalsHF® solution.
  ogimage: >-
    https://mk0hitconsultan2lp7c.kinstacdn.com/wp-content/uploads/2021/07/Products_BioVitalsHF_Screens2.png
  ogsite_name: null
  ogtitle: >-
    Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic
    for Heart Failure
  ogtype: article
  ogupdated_time: null
  ogurl: >-
    https://hitconsultant.net/2021/07/30/biofourmis-earns-fda-breakthrough-device-designation/
  yandex-verification: null
  robots: 'index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1'
  fbapp_id: null
  oglocale: en_US
  fbadmins: null
  articlepublisher: 'https://www.facebook.com/pages/HIT-Consultant-Media/302199219847409'
  google-site-verification: ZfA9TYzJhTo4Qq5hZKk2GVBYHj0-7Bu73PO0P5jbDaI
  keywords: null
id: 7399
identifier: News
lastMod: '2021-08-02T05:38:52.207375Z'
link:
  brand: hitconsultant.net
  href: >-
    https://hitconsultant.net/2021/07/30/biofourmis-earns-fda-breakthrough-device-designation/#.YQeDu45KhPY
  original: >-
    https://hitconsultant.net/2021/07/30/biofourmis-earns-fda-breakthrough-device-designation/#.YQeDu45KhPY
href: >-
  https://hitconsultant.net/2021/07/30/biofourmis-earns-fda-breakthrough-device-designation/#.YQeDu45KhPY
original: >-
  https://hitconsultant.net/2021/07/30/biofourmis-earns-fda-breakthrough-device-designation/#.YQeDu45KhPY
mastHead: NEWS
mdName: dcc07e0b-7e22-59e2-94da-23a5b92ee9e4.md
openGraphMetaData:
  ogdescription: >-
    Biofourmis receives FDA Breakthrough Device designation for the first-ever
    heart failure digital therapeutic, BiovitalsHF® solution.
  ogtitle: >-
    Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic
    for Heart Failure
  ogurl: >-
    https://hitconsultant.net/2021/07/30/biofourmis-earns-fda-breakthrough-device-designation/
  ogimage: >-
    https://mk0hitconsultan2lp7c.kinstacdn.com/wp-content/uploads/2021/07/Products_BioVitalsHF_Screens2.png
  ogsite_name: null
  ogtype: article
  ogupdated_time: null
  ogimageheight: '594'
openProjectCustomFields:
  cleanUrl: >-
    https://hitconsultant.net/2021/07/30/biofourmis-earns-fda-breakthrough-device-designation/#.YQeDu45KhPY
  medigyTopics:
    - 'Medical Subject Headings (MeSH): Cardiology'
    - 'U.S. Food and Drug Administration (FDA): Medical Device Data Systems'
    - 'Medigy: Digital Medical Devices'
  sourceUrl: >-
    https://hitconsultant.net/2021/07/30/biofourmis-earns-fda-breakthrough-device-designation/#.YQeDu45KhPY
openProjectWorkPackageType: Curated Content
searchCategory: News
slug: >-
  hitconsultant-biofourmis-earns-fda-breakthrough-device-designation-for-digital-therapeutic-for-heart-failure
source: open-project-curations
status: ''
sub: brief
tags:
  - News
title: >-
  Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic
  for Heart Failure
via: ' '
insights_description: null
insights_name: null
viaLink: null
relatedOfferings:
  - label: MyCellHub NV - Electronic Batch Records
    permalink: /offering/mycellhub-nv---electronic-batch-records
    categories:
      - 'Medigy: Digital Medical Devices'
    offeringId: 17742
  - label: NetBrain Technologies - Hybrid Cloud Visibility
    permalink: /offering/netbrain-technologies---hybrid-cloud-visibility
    categories:
      - 'Healthcare IT News: Cloud-Connected Devices'
      - 'Medigy: Digital Medical Devices'
    offeringId: 17723
  - label: Climedo Health GmbH - EDC system
    permalink: /offering/climedo-health-gmbh---edc-system
    categories:
      - 'Medigy: Digital Medical Devices'
      - 'Medical Subject Headings (MeSH): Electronic Data Processing'
    offeringId: 17711
  - label: LumiraDx Platform
    permalink: /offering/lumiradx-platform
    categories:
      - 'Medigy: Digital Diagnostics'
      - 'Medigy: Digital Medical Devices'
    offeringId: 10827
  - label: 5 x SIFTHERMO-2.21B
    permalink: /offering/5-x-sifthermo-2-21b
    categories:
      - 'KLAS: Remote Patient Monitoring'
      - 'Gartner: Remote Diagnostics'
      - 'Symplur: #digitalhealth'
      - 'Medigy: Digital Medical Devices'
    offeringId: 8637
twitterMetaData:
  twittercard: summary
  twitterdescription: >-
    Biofourmis receives FDA Breakthrough Device designation for the first-ever
    heart failure digital therapeutic, BiovitalsHF® solution.
  twittertitle: >-
    Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic
    for Heart Failure
  twitterimage: null
  twitterurl: null
---
<p>– <a href="http://www.biofourmis.com/">Biofourmis</a>, a Boston-based global leader in virtual care and digital therapeutics, announced its BiovitalsHF® solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA).</p><p>– The Breakthrough Devices Program was created to provide patients and providers with timely access to medical devices (in this case, software as a medical device, or SaMD) by speeding up their development, assessment, and review while preserving the statutory standards for premarket approval, 510(k) clearance, and De Novo marketing authorization, according to the FDA.</p>